Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Budman

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Cancer Investigation|January 1, 1997
Vinorelbine (Navelbine): a third-generation vinca alkaloidD R Budman
Investigational New Drugs|November 18, 2000
CapecitabineD R Budman
Seminars in Oncology|December 1, 1996
Early studies of etoposide phosphate, a water-soluble prodrugD R Budman
Seminars in Oncology|December 1, 1992
New vinca alkaloids and related compoundsD R Budman
Cancer Research|July 1, 1992
Correspondence Re: L.E. Damon et al., Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine. Cancer Res., 51: 4141-4145, 1991W Kreis, D R Budman
Annals of Internal Medicine|February 1, 1977
Hematologic aspects of systemic lupus erythematosus. Current conceptsD R Budman, A D Steinberg
Clinical Obstetrics and Gynecology|December 1, 1994
Adjuvant therapy for breast cancerD R Budman, M L Citron
Archives of Internal Medicine|September 1, 1976
Hypertension and renal disease in systemic lupus erythematosusD R Budman, A D Steinberg
British Journal of Urology|February 1, 1997
Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell linesW Kreis, D R Budman, A Calabro
Anti-Cancer Drugs|November 21, 1998
In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agentsD R Budman, A Calabro, W Kreis
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Cancer Investigation|January 1, 1997
Vinorelbine (Navelbine): a third-generation vinca alkaloidD R Budman
Investigational New Drugs|November 18, 2000
CapecitabineD R Budman
Seminars in Oncology|December 1, 1996
Early studies of etoposide phosphate, a water-soluble prodrugD R Budman
Seminars in Oncology|December 1, 1992
New vinca alkaloids and related compoundsD R Budman
Cancer Research|July 1, 1992
Correspondence Re: L.E. Damon et al., Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine. Cancer Res., 51: 4141-4145, 1991W Kreis, D R Budman
Annals of Internal Medicine|February 1, 1977
Hematologic aspects of systemic lupus erythematosus. Current conceptsD R Budman, A D Steinberg
Clinical Obstetrics and Gynecology|December 1, 1994
Adjuvant therapy for breast cancerD R Budman, M L Citron
Archives of Internal Medicine|September 1, 1976
Hypertension and renal disease in systemic lupus erythematosusD R Budman, A D Steinberg
British Journal of Urology|February 1, 1997
Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell linesW Kreis, D R Budman, A Calabro
Anti-Cancer Drugs|November 21, 1998
In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agentsD R Budman, A Calabro, W Kreis
Pageof 11